COG — Cambridge Cognition Holdings Share News
0.000.00%
- £13.63m
- £13.63m
- £10.34m
REG - AIM - AIM Notice - 02/09/2025
AnnouncementRCS - Cambridge Cognition - Investor Presentation via Investor Meet Company
AnnouncementREG - Cambridge Cognition - £1.12m Placing & Subscription, TVR & PDMR Dealings
AnnouncementREG - Cambridge Cognition - Changes to Board and Management
AnnouncementREG - Cambridge Cognition - Interim Results
AnnouncementRCS - Cambridge Cognition - Monument Therapeutics Partnership with FNIH
AnnouncementREG - Cambridge Cognition - Launch of Speaker Identification Solution
AnnouncementREG - Cambridge Cognition - Trading update for period ended 30 June 2025
AnnouncementREG - Cambridge Cognition - Result of AGM
AnnouncementRCS - Cambridge Cognition - Monument Therapeutics Success in Phase I Results
AnnouncementREG - Cambridge Cognition - Notice of AGM
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Preliminary Unaudited Results
AnnouncementREG - Cambridge Cognition - Notice of Results and Investor Presentation
AnnouncementREG - Cambridge Cognition - Contract Win
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Contract Win
AnnouncementREG - Cambridge Cognition - Block Listing Return
AnnouncementRCS - Cambridge Cognition - CANTAB® used for major global brain health study
Announcement